Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (2393)	2/18/1998 4:23:00 PM
From: Linda Kaplan	Read Replies (3) \| Respond to of 7041

Dauntless, There were two paragraphs on Zonagen. One on page one and one on page two, but the second paragraph reiterated the first paragraph and expanded the details. I posted all the relevant details about Zonagen that were in the report. But perhaps there is supplementary information that you can dig up? I think there has to be high, low and medium doses of Vasomax. Wessels, Arnold & Henderson is supposed to have a good rep and it would not provide any advantage to them to create a report of this kind that isn't accurate, for they are accountable to their clients, after all and the investment community as a whole. Isn't the conference being held by the very people (Wessels, Arnold & Henderson) who prepared this report? Yes, you're right. The report discusses VVUS, recommending a "Hold" on VVUS, and I didn't mention that. But there wasn't anything else about Zonagen. Linda

To: Dauntless who wrote (2393)	2/18/1998 4:50:00 PM
From: Samuel Seward	Respond to of 7041

Daunt, There are two interesting points about this report. One, as you pointed out there seems to have been some advance knowledge of the report by some posters. Two, as with the original negative reports, it coincides with the absence of the corporate officers from the home office. Sam

To: Dauntless who wrote (2393)	2/18/1998 4:51:00 PM
From: Bill Wexler	Respond to of 7041

Zonagen continues its price decline Zonagen does not have an effective ED medication. Phentolamine has not been proven to help ED, even when injected. Zonagen has a history of stock manipulation, fraud, and dirty dealing.